楚江新材(002171.SZ):天鳥高新對其全資子公司增資1.5億元
格隆匯11月12日丨楚江新材(002171.SZ)公佈,公司於2021年11月12日召開的第五屆董事會第二十二次會議審議通過了《關於控股子公司天鳥高新對其全資子公司增資的議案》,為適應公司發展的需要,充分發揮子公司的資本實力,實現公司做大做強目標,同意公司控股子公司天鳥高新對其全資子公司蕪湖天鳥增資1.5億元人民幣。蕪湖天鳥原註冊資本為5000萬元人民幣,增資後註冊資本為2億元人民幣,天鳥高新持有其100%股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.